Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Clinical trial NCT01700140 · COMPLETED
Trial details
- NCT number
- NCT01700140
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-10-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.